Predicting cancer development in oral leukoplakia: Ten years of translational research

Clinical Cancer Research

Volumn 6, Issue 5, 2000, Pages 1702-1710

  Lee, J Jack ^a   Hong, Waun Ki ^a   Hittelman, Walter N ^a   Mao, Li ^a   Lotan, Reuben ^a   Shin, Dong M ^a   Benner, Steven E ^b   Xu, Xiao Chun ^a   Lee, Jin S ^a   Papadimitrakopoulou, Vali M ^a   Geyer, Clarissa ^a   Perez, Cherie ^a   Martin, Jack W ^a   El Naggar, Adel K ^a   Lippman, Scott M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; RETINOID DERIVATIVE;

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HETEROZYGOSITY LOSS; HUMAN; LEUKOPLAKIA; MALE; MALIGNANT TRANSFORMATION; MOUTH CANCER; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ALCOHOL DRINKING; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 9; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOTRETINOIN; LEUKOPLAKIA, ORAL; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MOUTH; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, RETINOIC ACID; RISK FACTORS; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0343091242     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kramer, I. R., Lucas, R. B., Pindborg, J. J., and Sobin, L. H. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg. Oral Med. Oral Pathol., 46: 518-539, 1978.
2. Silverman, S. Jr. (ed.). Oral Cancer, Ed. 3. Atlanta, GA: American Cancer Society, 1990.
3. Slaughter, D. P., Southwick, H. W., and Smejkal, W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer (Phila.), 6: 963-968, 1953.
4. Norton S. A. Betel: consumption and consequences. J. Am. Acad. Dermatol., 38: 81-88, 1998.
5. Silverman, S., Jr., Gorsky, M., and Lozada, F. Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer (Phila.), 53: 563-568, 1984.
6. Silverman, S., Jr., and Gorsky, M. Proliferative verrucous leukoplakia: a follow-up study of 54 cases. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 84: 154-157, 1997.
7. Hong, W. K., Endicott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., et al. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med., 315: 1501-1505, 1986.
8. Hong, W. K., Lippman, S. M., Itri, L. M., et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795-801, 1990.
9. Hong, W. K., Lippman, S. M., Hittelman, W. N., and Lotan, R. Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic. Clin. Cancer Res., 1: 677-686, 1995.
10. Lippman, S. M., Batsakis, J. G., Toth, B. B., Weber, R. S., Lee, J. J., Martin, J. W., Hays, G. L., Goepfert, H., and Hong, W. K. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N. Engl. J. Med., 328: 15-20, 1993.
11. Papadimitrakopoulou, V. A., Hong, W. K., Lee, J. S., Martin, J. W., Lee, J. J., Batsakis, J. G., and Lippman, S. M. Low-dose isotretinoin versus β-carotene to prevent oral carcinogenesis: long-term follow-up. J. Natl Cancer Inst., 89: 257-258, 1997.
12. Lippman, S. M., Shin, D. M., Lee, J. J., Batsakis, J. G., Lotan, R., Tainsky, M. A., Hittelman, W. N., and Hong, W. K. p53 and retinoid chemoprevention of oral carcinogenesis. Cancer Res., 55: 16-19, 1995.
13. Lotan, R., Xu, X. C., Lippman, S. M., Ro, J. Y., Lee, J. S., Lee, J. J., and Hong, W. K. Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N. Engl. J. Med., 332: 1405-1410, 1995.
14. Xu, X. C., Zile, M. H., Lippman, S. M., Lee. J. S., Lee, J. J., Hong, W. K., and Lotan, R. Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor β expression. Cancer Res., 55: 5507-5511, 1995.
15. Shin, D. M., Xu, X. C., Lippman, S. M., Lee, J. J., Lee, J. S., Batsakis, J. G., Ro, J. Y., Martin, J. W., Hittelman, W. N., Lotan, R., and Hong, W. K. Accumulation of p53 protein and retinoic acid receptor β in retinoid chemoprevention. Clin. Cancer Res., 3: 875-880, 1997.
16. Benner, S. E., Lippman, S. M., Wargovich, M. J., Lee, J. J., Velasco, M., Martin, J. W., Toth, B. B., and Hong, W. K. Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral pre-malignancy. Int. J. Cancer, 59: 457-459, 1994.
17. Mao, L., Lee, J. S., Fan, Y. U., Ro, Batsakis, J. G., Lipman, S., Hittelman, W., and Hong, W. K. Frequent microsatellite alterations at chromosome 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat. Med., 2: 682-685, 1996.
18. Hittelman, W. N., Kim, H. J., Lee, J. S., Shin, D. M., Lippman, S. M., Kim, J., Ro, J. Y., et al. Detection of chromosome instability of tissue fields at risk: in situ hybridization. J. Cell. Biochem. Suppl., 25S: 57-62, 1996.
19. Geyer, C., Papadimitrakopoulou, V., Lee, J. S., Lippman, S. M., Xu, X. C., Lee, J. J., Hong, W. K., and Lotan, R. A lack of association among the basal level of retinoic acid receptor β mRNA in oral premalignant lesions, its up-regulation by 13-cis-retinoic acid and cancer development during a long-term follow-up. Proc. Am. Soc. Clin. Oncol., 17: 391, 1998.
20. Rosin, M. P., Epstein, J. B., Berean, K., Durham, S., Hay, J., Cheng, X., Zeng, T., Huang, Y., and Zhang, L. The use of exfoliative cell samples to map clonal genetic alterations in the oral epithelium of high-risk patients. Cancer Res., 57: 5258-5260, 1997.
21. Cox, D. R., and Oakes, D. Analysis of Survival Data. New York: Chapman and Hall, 1984.
22. Lee, J. J., Hess, K. R., and Dubin, J. A. Extensions and applications of event charts. Am. Statistician, 54: 63-70, 2000.
23. S-PLUS User's Guide. Seattle, WA: Data Analysis Products Division. MathSoft, Inc., 1997.
24. Therneau, T. M., and Atkinson, E. J. An introduction to recursive partitioning using the RPART routines. Mayo Clinic Biostatistics Technical Report 61, Rochester, MN, 1997.
25. Hong, W. K., and Sporn, M. B. Recent advances in chemoprevention of cancer. Science (Washington DC), 278: 1073-1077, 1997.
26. Lippman, S. M., Lee, J. J., and Sabichi, A. L. Cancer chemoprevention: progress and promise. J. Natl. Cancer Inst., 90: 1514-1528, 1998.
27. Rudin, C. M., Recant, W., Bennett, P., Sulzen, L., Kirn, D. H., and Vokes, E. E. Preliminary report: adenovirus ONYX-015 administered by mouthwash as a chemopreventive agent and for the treatment of oral dysplastic lesions. Proc. Am. Soc. Clin. Oncol., 18: 445, 1999.
28. Clayman, G. L., El-Naggar, A. K., Lippman, S. M., Henderson, Y. C., Frederick, M., Merritt, J. A., Zumstein, L. A., Timmons, T. M., Liu, T. W., Ginsberg, L., Roth, J. A., Hong, W. K., Bruso, P., and Goepfert, H. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J. Clin. Oncol., 16: 2221-2232, 1998.
29. Mao L. Can molecular assessment improve classification of head and neck premalignancy? Clin. Cancer Res., 6: 321-322, 2000.